Private company
Immune Therapy Holdings
Logo: https://ithgroup.se/, Non-free logo, via Wikipedia3
Swedish biotechnology R&D holding company
Immune Therapy Holdings AB or ITH is a Swedish biotechnology R&D holding company headquartered at the Karolinska Institutet and Karolinska University Hospital in Stockholm. ITH's research is primarily focused on its Tailored Leukapheresis (TLA) treatment for immune mediated inflammatory diseases (IMIDs).2 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
- Industryresearch and development1
- HeadquartersStockholm1
- Websitewww.ithgroup.eu
See how the biggest companies compare on our leaderboards
Immune Therapy Holdings AB or ITH is a Swedish biotechnology R&D holding company headquartered at the Karolinska Institutet and Karolinska University Hospital in Stockholm. ITH's research is primarily focused on its Tailored Leukapheresis (TLA) treatment for immune mediated inflammatory diseases (IMIDs).2
Products and brands
- immunotherapy
Listed on Wikidata.1
Timeline
- 2005Founded Founded1
Links
- Websitewww.ithgroup.eu1
- WikipediaImmune Therapy Holdings
- WikidataQ16847440
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2WikipediaImmune Therapy Holdings on Wikipedia
- 3Wikimedia CommonsImmune Therapy Holdings logo by https://ithgroup.se/, Non-free logo